About 25% of former National Football League players who died between 2016 and 2021 showed signs of chronic traumatic encephalopathy (CTE) [1].
This finding represents a shift in how researchers understand the prevalence of the degenerative brain disease. Because the study provides a population-based estimate, it offers a more comprehensive view than previous community-based studies that relied on voluntary brain donations.
The research, published in the British Medical Journal (BMJ) this month [4], examined players who died during a six-year window from 2016 to 2021 [1]. The results indicate that at least one-quarter of those players had the condition at the time of death [1].
CTE is a brain disease associated with repeated head trauma. While previous reports have highlighted the risks of the sport, this specific data set provides a broader statistical baseline for the league's former athletes [2].
Robert Glatter said a new BMJ study offers the first population-based CTE prevalence estimate for NFL players, finding a minimum of 25% among those who died from 2016-2021 [4].
The study sought to determine the actual frequency of the disease across a general sample of deceased players rather than a selected group [2]. This methodology helps researchers avoid the bias found in earlier studies, where families were more likely to donate the brains of players who had already shown symptoms of cognitive decline [2].
Medical professionals use the BMJ findings to better understand the long-term neurological impact of professional football. The data underscores a persistent link between the sport's physical demands and permanent brain damage [3].
“About 25% of former National Football League players who died between 2016 and 2021 showed signs of chronic traumatic encephalopathy.”
By moving from community-based samples to a population-based estimate, this study reduces the 'selection bias' that often plagues CTE research. Previously, higher percentages were often reported because the brains studied came from families who suspected the player had the disease. A 25% prevalence rate across a broader population still suggests a significant public health concern for retired athletes and may influence future safety protocols and legal settlements regarding player health.
